2-氯喹唑啉 | 6141-13-5

• 物质功能分类: 医药中间体
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 中文名称: 2-氯喹唑啉
• 中文别名: 柠檬酸钠二水合物；2-氯喹啉唑啉
• 英文名称: 2-chloroquinazoline
• CAS: 6141-13-5
• 化学式: C₈H₅ClN₂
• mdl: MFCD09959715
• 分子量: 164.594
• InChiKey: WMPTYRGXBUYONY-UHFFFAOYSA-N

物化性质

• 熔点：
  108 °C(Solv: ligroine (8032-32-4))
• 沸点：
  250.0±13.0 °C(Predicted)
• 密度：
  1.349±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Chloroquinazoline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Chloroquinazoline
CAS number: 6141-13-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H5ClN2
Molecular weight: 164.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

应用

2-氯喹唑啉是一种有机中间体，可通过亚苯甲酰基脲制备。具体步骤是先合成2,4-二氯喹唑啉，再进行脱氯反应得到目标产物。

制备 2,4-二氯喹唑啉 (IIIA)

将2.0克亚苯甲酰基脲和0.6毫升N,N-二甲基苯胺加入到6毫升三氯氧磷中，在回流条件下反应7小时。冷却至室温后，减压除去大部分三氯氧磷，剩余液体转移至冰水中搅拌，产生大量土黄色固体。抽滤并用蒸馏水洗涤滤饼后干燥，得到1.6克黄绿色固体(IIIA)，产率为65%；熔点为118-119℃；1H-NMR (400 Hz, CDCl3) δ: 7.75-7.79(m, 1H), 8.02-8.03(m, 2H), 8.29(d, J=8.4Hz, 1H)。

2-氯喹唑啉 (IIIB)

将0.5克2,4-二氯喹唑啉(IIIA)、含9% NH4OH的饱和盐水10毫升和0.5克活化锌粉加入到装有10毫升二氯甲烷的茄型烧瓶中，在回流条件下反应4小时。冷却后，抽滤除去锌粉，减压蒸除溶剂，用乙酸乙酯萃取有机层。经干燥、过滤并减压蒸除溶剂后，通过柱层析分离得到0.2克2-氯喹唑啉(IIIB)，产率为40%。

反应信息

• 作为反应物：
  描述：

  2-氯喹唑啉 在 盐酸 作用下， 生成 3-(氯甲基)-6-(三氟甲基)吡啶
  参考文献：
  名称：

  Bogert; May, Journal of the American Chemical Society, 1909, vol. 31, p. 512

  摘要：

  DOI：
• 作为产物：
  描述：

  2,4-喹唑啉二酮 在 氨 、 二乙胺 、 sodium chloride 、 锌 、 三氯氧磷 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 0.5h， 生成 2-氯喹唑啉
  参考文献：
  名称：

  微波辅助合成喹啉，异喹啉，喹喔啉和喹唑啉衍生物作为CB2受体激动剂

  摘要：

  使用微波辅助合成法合成喹啉，异喹啉，喹喔啉和喹唑啉衍生物，并使用[ 35 S]GTPγS结合测定法测定其CB1 / CB2受体活性。大部分制备的喹啉，异喹啉和喹喔啉基苯胺均显示出低效的部分CB2受体激动剂活性。最有效的CB2配体是4-吗啉基甲酮衍生物（化合物40e）（-log EC 50  = 7.8；E max  = 75％）。异喹啉-1-基（3-三氟甲基-苯基）胺（化合物26c）是一种高效的CB2激动剂（-log EC 50  = 5.8; E max = 128％）。在这些研究中，没有发现明显的CB1受体激活或失活，除了40e表现出弱的CB1激动剂活性（CB1-log EC 50  = 5.0）。这些配体用作开发选择性CB2受体激动剂的新型模板。

  DOI：

  10.1016/j.bmc.2010.11.059

文献信息

• [EN] THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE<br/>[FR] DÉRIVÉS DE THIOPHÈNE POUR LE TRAITEMENT DE TROUBLES PROVOQUÉS PAR IGE
  申请人：UCB BIOPHARMA SRL

  公开号：WO2019243550A1

  公开（公告）日：2019-12-26

  Thiophene derivatives of formula (I) and a pharmaceutically acceptable salt thereof are provided. These compounds have utility for the treatment or prevention of disorders caused by IgE, such as allergy, type 1 hypersensitivity or familiar sinus inflammation.

  提供了公式（I）的噻吩衍生物及其药用可接受的盐。这些化合物对于治疗或预防由IgE引起的疾病具有用途，如过敏、1型超敏反应或家族性鼻窦炎。
• [EN] CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF<br/>[FR] MODULATEURS DE CALPAÏNE ET LEURS UTILISATIONS THÉRAPEUTIQUES
  申请人：BLADE THERAPEUTICS INC

  公开号：WO2019190885A1

  公开（公告）日：2019-10-03

  Small molecule calpain modulator compounds, including their pharmaceutically acceptable salts, can be included in pharmaceutical compositions. The compounds can be useful in inhibiting calpain, or competitive binding with calpastatin, by contacting them with CAPN1, CAPN2, and/or CAPN9 enzymes residing inside a subject. The compounds and composition can also be administered to a subject in order to treat a fibrotic disease or a secondary disease state or condition of a fibrotic disease.

  小分子钙蛋白酶调节剂化合物，包括其药用可接受的盐，可以包含在药物组合物中。这些化合物可以通过与主体内的CAPN1、CAPN2和/或CAPN9酶接触来抑制钙蛋白酶，或与钙蛋白酶抑制剂竞争性结合。这些化合物和组合物也可以被用于治疗纤维化疾病或纤维化疾病的继发疾病状态或病情。
• HETEROBICYCLIC COMPOUNDS
  申请人：Amgen Inc.

  公开号：US20130225552A1

  公开（公告）日：2013-08-29

  Heterobicyclic compounds of Formula (I): or a pharmaceutically-acceptable salt, tautomer, or stereoisomer thereof, as defined in the specification, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, Huntington's Disease, and the like.

  Formula (I)的杂环化合物： 或其药用可接受的盐、互变异构体或立体异构体，如规范中所定义，并含有它们的组合物，以及制备这种化合物的方法。本文还提供了通过抑制PDE10来治疗由此可治疗的疾病或疾病的方法，如肥胖症、非胰岛素依赖型糖尿病、精神分裂症、躁郁症、强迫症、亨廷顿病等。
• PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
  申请人：ANDERSON MARK B.

  公开号：US20100068197A1

  公开（公告）日：2010-03-18

  Disclosed are compounds of Formula I effective as cytotoxic agents. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  揭示的是作为细胞毒性剂有效的I式化合物。本发明的化合物在治疗多种临床病况中是有用的，这些病况中发生异常细胞的不受控制的生长和扩散。
• [EN] COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION<br/>[FR] COMPOSÉS MODULANT LE RECRUTEMENT ET/OU LA DÉGRADATION DE PROTÉINES
  申请人：ORIONIS BIOSCIENCES INC

  公开号：WO2021126973A1

  公开（公告）日：2021-06-24

  The invention provides cereblon binders for the degradation of proteins by the ubiquitin proteasome pathway for therapeutic applications.

  这项发明提供了用于通过泛素蛋白酶体途径降解蛋白质的 cereblon 结合物，用于治疗应用。